Reduced melanocortin production causes sexual dysfunction in male mice with POMC neuronal insulin and leptin insensitivity.
Latrice D Faulkner, Abigail R Dowling, Ronald C Stuart, Eduardo A Nillni, Jennifer W Hill
Index: Endocrinology 156(4) , 1372-85, (2015)
Full Text: HTML
Abstract
Proopiomelanocortin (POMC)-derived peptides like α-melanocyte-stimulating hormone (MSH) substantially improve hepatic insulin sensitivity and regulate energy expenditure. Melanocortinergic agents are also powerful inducers of sexual arousal that are being investigated for a possible therapeutic role in erectile dysfunction. It is currently unclear whether reduced melanocortin (MC) activity may contribute to the sexual dysfunction accompanying obesity and type 2 diabetes. Male rodents with leptin and insulin resistance targeted to POMC neurons (leptin receptor [LepR]/insulin receptor [IR]POMC mice) exhibit obesity, hyperinsulinemia, hyperglycemia, and systemic insulin resistance. In this study, we demonstrate that LepR/IRPOMC males are also subfertile due to dramatic alterations in sexual behavior. Remarkably, these reproductive changes are accompanied by decreased α-MSH production not present when a single receptor type is deleted. Unexpectedly, behavioral sensitivity to α-MSH and MC receptor expression are also reduced in LepR/IRPOMC males, a potential adaptation of the MC system to altered α-MSH production. Together, these results suggest that concurrent insulin and leptin resistance in POMC neurons in individuals with obesity or type 2 diabetes can reduce endogenous α-MSH levels and impair sexual function.
Related Compounds
Related Articles:
2014-01-01
[Nucleic Acids Res. 42(17) , e130, (2014)]
2015-03-15
[Toxicol. Appl. Pharmacol. 283(3) , 187-97, (2015)]
2014-01-01
[PLoS ONE 9(6) , e99421, (2014)]
Selective inhibition of RET mediated cell proliferation in vitro by the kinase inhibitor SPP86.
2014-01-01
[BMC Cancer 14 , 853, (2014)]
Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance.
2015-04-01
[Cancer Res. 75(7) , 1457-69, (2015)]